Close Menu

In Cell this week, researchers in Italy say that TAZ, a transducer of the Hippo pathway, is responsible for conferring the properties of cancer stem cells onto breast cancer cells. TAZ is required to sustain self-renewal and tumor-initiation capacities in breast cancer stem cells, the authors write. "TAZ protein levels and activity are elevated in prospective CSCs and in poorly differentiated human tumors and have prognostic value," they add.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.